Chapter 10: Microbial Genomics and Other Omics

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

It's amazing, isn't it, how we've gone from barely understanding DNA to decoding entire genomes like we suddenly have these instruction manuals for life itself.

And speaking of deep knowledge, that's exactly where we're headed today.

Right into the heart of genomics, synthetic biology, and evolution, all based on that huge summary you sent over.

Exactly.

It's really striking how sequencing and analyzing genomes has transformed microbiology and biology as a whole.

We'll be looking at everything from how these tiny organisms work to their interactions, and even how they affect us through that systems biology lens.

It is a pretty massive field.

It is.

But we're going to break it down in a way that's clear, engaging,

and hopefully fun.

So no need to feel overwhelmed.

Let's start with the basics.

Genomics.

What is it really?

Well, genomics is all about mapping, sequencing, analyzing, and comparing entire genomes, basically an organism's complete genetic blueprint.

Right.

And that blueprint is made up of DNA, which is the actual genetic material.

Precisely.

And what's really changed the game is automation and how much faster and cheaper it's become to sequence a genome.

This has opened up a whole new world of understanding in biology.

And summary highlights how this has impacted microbiology in some pretty remarkable ways.

Absolutely.

Genomics has revealed the genetic basis for so many microbial traits.

Take heat stable enzymes, which are incredibly useful in various industrial processes.

Right.

I remember reading about those.

Genomics pinpoints the exact genes that make them so resistant to high temperatures.

And we can do the same for virulence factors in disease causing microbes.

It's also given us tools like microarrays, allowing us to study the activity of thousands of genes simultaneously.

It's like having a high resolution snapshot of what's happening in the microbial world.

Exactly.

And it's helped us understand horizontal gene transfer, how microbes swap genetic material, which is a big deal for antibiotic resistance.

Genomics has even helped us solve historical mysteries, like identifying Yersinia pestis as the cause of the Black Death.

And then there's the discovery of CRISPRs, these amazing bacterial defense systems that have revolutionized gene editing.

I remember when CRISPR first hit the scene.

It was huge.

And speaking of big discoveries, the summary mentions vast databases like Gold D, these public repositories of genomic information.

It's a huge collaborative effort.

Initiatives like JGI and JBA are working to fill in the gaps in our knowledge of genomic diversity.

But even with all this data, there's still so much microbial life we haven't explored at the genetic level.

For context, the human genome has around 21 ,000 protein encoding genes.

21 ,000.

Yes, around that.

But the microbial world is vastly more diverse.

That's mind boggling.

We've already found genes for those heat stable enzymes, virulence factors, even discovered entirely new phylae of microbes like thalmarkeota.

It's amazing how much we're learning.

It is.

And it all starts with sequencing.

Right.

So how do we go from a biological sample to that string of A's, T's, C's, and G's?

And then how do we make sense of it all?

Well, it all starts with DNA sequencing.

The summary mentions the Sanger method, the original technique.

It was slow, but it laid the foundation.

It used these special molecules called DDNTPs to create DNA fragments of links.

Sort of like reading the code letter by letter, right?

Exactly.

Then came second generation sequencing like pyro sequencing, which uses light emission, and Illumina, which can sequence millions of DNA fragments at once.

So going from reading one book at a time to reading an entire library simultaneously.

Yeah, a perfect analogy.

And now we have third generation methods like Pacific Biosciences, SMRT, and Oxford Nanopore offering even longer reads, which are essential for assembling complex genomes.

And some can even sequence single DNA molecules.

It's like putting together a puzzle with larger pieces.

Precisely.

And once you have these raw sequences, you need to assemble them.

Computer programs identify overlapping sequences and piece them together to form contigs, like paragraphs, and then scaffolds, like chapters in the Book of Life.

That's why there's a long string of letters.

But how do we find the actual genes and figure out what they do?

That's where genome annotation comes in.

It's about turning that raw data into a meaningful list of genes and other functional elements.

And this is where bioinformatics is essential.

We look for open reading frames, or ORFs, which are potential protein coding regions.

We look for start codons, stop codons, ribosome binding sites, even things like codon bias.

So like deciphering the instructions, finding where they start and stop, and then trying to figure out what they mean.

Precisely.

Then to determine their function, we compare these sequences to databases like GenBank using tools like BLAST.

If our new gene resembles a gene with a known function, we can infer a simile function for the new one.

Makes sense.

But the summary points out that many genes are classified as hypothetical proteins because we don't know their function yet.

It highlights how much we still have to learn.

It's incredible.

Even with all this technology, we still have so much to discover.

Now the summary delves into genome size and content, especially in prokaryotes.

Right.

So generally larger genomes have more ORFs, about a thousand per megabase pair.

However, bacterial genomes vary a lot in size, while arkyl genomes are more consistent.

So bigger isn't always better.

Not necessarily.

Take parasitic or endosymbiotic bacteria like Nasuia delta cephalinicola.

It has a tiny genome of only 112 kilobase pairs.

Wow, that's small.

It's stripped down to the essentials, relying on its host for other functions.

Estimates suggest free living cells need at least 250 to 300 genes, although metagenomic data might suggest even fewer.

So some microbes are incredibly efficient with their genetic material.

Exactly.

Larger genomes tend to have more genes for regulation and signal transduction responding to their environment.

Smaller genomes often dedicate more to protein synthesis, the basics of making proteins.

Makes sense.

And it's not just protein coding genes.

We also have genes for tRNAs, rRNAs, and various regulatory RNAs.

The challenge with non -coding regulatory RNAs is that their function often lies in their structure, not just the sequence.

This is where techniques like transcriptomics comes handy.

So more tools to understand this complex genetic landscape.

What about organelles like mitochondria and chloroplasts and eukaryotic microbes?

How do their genomes compare?

Well, mitochondria and chloroplasts are thought to have originated from free living bacteria, the endosymbiotic theory.

They still have their own genomes, but they're small and circular.

Chloroplast genomes mainly encode proteins for photosynthesis, while mitochondrial genomes focus on oxidative phosphorylation, the energy production process.

So their genomes reflect their specialized roles in the cell.

Exactly.

Most proteins working in these organelles are actually encoded by nuclear genes and imported in.

And when we look at eukaryotic microbes, their genome sizes and gene numbers can be all over the place.

All over the place.

Yes.

Some protozoans have more genes than

On the other hand, you have encephalidazone, an intracellular parasite with a tiny genome, even smaller than many bacteria, and it's even lost its mitochondria entirely.

Talk about streamlining your genome.

Right.

And another key feature of eukaryotic genomes is introns, these non -coding sequences within genes.

They're less frequent in microbial eukaryotes compared to complex multicellular organisms.

So we've covered how we read the genetic code, the types of information we're uncovering, and some key differences between life forms.

But just having the sequence isn't enough, right?

We need to know what those genes actually do.

Right.

So genomics gives us the parts list, but functional omics tells us what those parts do.

And as we mentioned, many ORFs remain a mystery.

So how do we crack the code of these unknown genes?

One powerful method is comparative genomics.

We compare a new genome to others, especially well -studied ones, to look for similar genes and infer potential functions.

It's based on the idea that genes with similar sequences often have similar roles.

So if a new organism has a gene that looks like a gene that does X in another organism, it probably does something similar.

Exactly.

Another technique is heterologous expression.

We express a gene from one organism in a model host like E.

coli and see what happens.

Kind of like a controlled environment to see how the gene behaves.

Right.

That's how scientists identified antibiotic resistance genes in a multi -drug resistant bacterium.

They expressed different genes in E.

coli to see which ones made it resistant.

And this approach can also help find new antiphage systems, bacterial defenses against viruses.

That's clever.

And the summary also talks about TINSEC, transposin sequencing.

Ah, TINSEC.

It's a great way to figure out gene function on a large scale.

You create a library of mutants, each with a transposin inserted into a different gene.

Then you expose them to specific conditions and see which mutants thrive or disappear.

So if a mutant with a disrupted gene struggles in a certain environment,

that gene is probably important for survival in that environment.

Exactly.

The idea is that the transposin disrupts the gene, affecting the mutant's fitness, and the abundance of each mutant reflects its fitness.

Essential genes won't have viable mutants.

It's a systematic way to figure out what genes do without studying each one individually.

Efficient and elegant.

And speaking of efficiency, metagenomics allows us to study organisms we can't even grow in the lab.

It's a game changer.

Metagenomics analyzes DNA or RNA from an environmental sample, capturing the genetic diversity of an entire microbial community, which we call the metagenome.

Most microbes are difficult or impossible to cultivate, so this allows us to study them directly in their natural habitats.

So even if we can't isolate individual species, we can still get a sense of what genes they have and what they might be doing.

Exactly.

We can look for specific groups of microbes, genes for things like antibiotic resistance, even without assembling complete genomes.

The summary also mentions the human microbiome, those trillions of bacteria living in and on us, mostly bacteroidates and firmicutes in the gut, and of course the mycobiome, the fungal part of these communities.

Our own personal ecosystems.

Fascinating.

So metagenomics gives us a broad overview, but how do we know which genes are actually being used under specific conditions?

That's where transcriptomics comes in, right?

Exactly.

Transcriptomics is all about the transcriptome all the RNA molecules present in a cell at a given time.

So it's a snapshot of which genes are active.

Right.

Before RNA sequencing became popular, scientists used gene ships, also known as micro -orays.

These are surfaces with thousands of tiny spots of DNA, each corresponding to a specific gene.

Like a genetic wanted poster.

Yeah, kind of.

You add labeled DNA or cDNA from your sample, and if a gene is being expressed, its cDNA binds to its spot on the chip.

It's a way to measure gene expression levels.

But RNA sequencing, or RNAseq, is much more powerful.

RNAseq has become the go -to method.

Why is that?

Well, with RNAseq, we isolate all the RNA, convert it to cDNA, and sequence it.

This tells us not only which genes are transcribed, but also how much RNA is produced for each gene.

Plus, we can study things like untranslated regions and non -coding RNAs.

It's become the standard in many areas of research.

So from DNA to RNA and now to proteins, the actual workhorses of the cell, how do we study them all?

That's the realm of proteomics.

It's the study of an organism's entire set of proteins, which is often called the proteome.

Sometimes, though, proteome can also refer to all the proteins that could be encoded by a genome.

The specific set of proteins present at a given time is sometimes called the translatome.

It sounds like there's a lot of nuance in how we define these terms.

There is.

Proteomics is essential because RNA levels don't always perfectly reflect protein levels.

You can have a lot of RNA, but not much protein, or vice versa.

Exactly.

Regulation can happen at the level of translation or protein stability.

And the main tool in proteomics is mass spectrometry.

Mass spectrometry.

Sounds so high -tech.

It is.

But the basic idea is to identify proteins based on their mass -to -charge ratio.

You digest proteins into smaller peptides, separate them by mass -to -charge ratio in the mass spectrometer, and then compare the results to databases to identify the proteins.

Advanced techniques can even tell you about post -translational modifications, the chemical changes that can happen to proteins.

So it's not just about the sequence of amino acids, but also how they're modified after they're made.

Right.

And just like metagenomics, we have metaproteomics for studying all the proteins in an environmental sample.

And then there's the interactome, which maps all the interactions between proteins in a cell.

So it's a network of all the protein players.

Exactly.

It helps us understand how proteins work together to carry out cellular processes.

Amazing.

So from DNA to RNA to proteins, we've covered the central dogma of molecular biology.

But what about all the other small molecules in the cell, the metabolites?

That's where metabolomics comes in.

It's the study of the metabolome, the metabolic intermediates, and small molecules like sugars, lipids, amino acids, and secondary metabolites.

It helps us understand metabolic pathways, how organisms respond to their environment, and even find biomarkers for diseases.

Metabolomics sounds incredibly complex.

It can be.

The sheer diversity of metabolites, their low concentrations, and the technical challenges of identifying them have made it lag behind other omics fields.

But techniques like mass spectrometry and nuclear magnetic resonance are getting better.

So we have genomics, all these functional omics, metagenomics, transcriptomics, codeomics, and metabolomics.

Each gives us a unique piece of the puzzle.

But how do we put it all together?

That's the beauty of systems biology.

It integrates all this data to build comprehensive models of biological systems.

It's about understanding the emergent properties, the complex behaviors that arise from the interactions of all these components.

So it's more than just the sum of its parts.

It's about how everything works together.

Exactly.

The summary highlights a couple of great examples.

One is single cell genomics, or SCGU.

It allows us to sequence the genomes of individual cells isolated from environmental samples.

Wow, that sounds challenging.

How do you even isolate and sequence the DNA from a single cell?

It involves techniques like dilution, encapsulation in micro droplets, or fluorescence activated cell sorting.

And then you need to amplify the DNA before sequencing.

Multiple displacement amplification, or MDA, is a common method for that.

So what's the big deal about studying single cells?

It reveals the diversity within a population.

Not all cells are the same, even within a seemingly uniform group.

We can see the different metabolic potentials of individual cells and even link genes to specific species in a complex sample.

It's like getting a personalized genetic profile for each cell.

Precisely.

And it's especially exciting for studying microbial dark matter.

Those microbes we know exist but haven't been able to cultivate.

Single cell genomics can give us clues about their characteristics and maybe even help us figure out how to grow them.

That's amazing.

And the summary also talks about how these integrated omics approaches are being used to study mycobacterium tuberculosis.

Right.

M -tuberculosis is a major health problem, and systems biology is helping us understand its pathogenesis, drug resistance, and dormancy mechanisms.

The goal is to find new drug targets.

One cool technique is dual RNA -seq, which allows us to see what genes are active in both the bacteria and the infected human cells at the same time.

So we can see how the pathogen and host are interacting at the genetic level.

Exactly.

This has revealed things like how M -tuberculosis uses host cholesterol for energy and the roles of specific proteins in infection.

Scientists have even mapped the M -tuberculosis interactome, the network of protein interactions, to find potential drug targets that won't harm human proteins or the good bacteria in our microbiome.

So it's about finding those Achilles heels, those specific vulnerabilities in the bacteria.

Precisely.

And proteomics and metabolomics are also helping us identify virulence factors and understand how the bacteria interacts with its host.

All these different omics data together are giving us new ways to think about treating tuberculosis.

It's like we're building this incredibly detailed intelligence report on the enemy.

And then the summary moves on to personalized medicine, the potential of systems biology to revolutionize health care.

It is a game changer.

As sequencing gets cheaper, we're finding millions of genomic variations that can affect our health and how we respond to drugs.

Personalized medicine aims to use this data to tailor health care for each individual.

So health care that's truly personalized.

Exactly.

The summary talks about an integrated personal omics profile, or IPOP, combining genomic, transcriptomic, proteomic, and metabolomic data.

This profile could provide a detailed picture of your health and even predict your risk for certain diseases.

There's even a case study about how an IPOP helped product type 2 diabetes.

It's like having a personalized health forecast.

That's incredible.

It is.

And this goes beyond just prediction.

Omics is also helping us understand the immune system, leading to new immunotherapy strategies, especially for cancer.

By analyzing an individual's immune system at the molecular level, we can develop more targeted and personalized therapies.

And systems biology is also helping us find new diagnostic markers for diseases by identifying unique molecular signatures associated with those diseases.

So we've gone from the basics of DNA to this incredible potential for personalized medicine.

It's amazing to think about how far we've come.

So just to recap, we started with genomics, learning how to read the blueprint of life.

Then we explored the different functional omics, metagenomics, transcriptomics, proteomics, and metabolomics, each one giving us a different perspective on how genes are expressed and function.

And finally, we looked at systems biology, which integrates all this data to understand complex biological systems as a whole.

Yes.

And hopefully this deep dive has been both comprehensive and, well, digestible.

We covered a lot of ground.

We did.

But in a way that hopefully makes sense and sparks curiosity.

What's clear is that these omics approaches are transforming our understanding of life, especially in the microbial world.

And this understanding is leading to real benefits for human health.

As we wrap up, I'm left wondering.

With this incredible power to read, and perhaps even rewrite, the code of life, what amazing discoveries await us in the future?

It's an exciting time to be alive.